Pfizer earnings were -$2.6B for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest PFE earnings report on Jun 30, 2024 announced Q2 2024 earnings of $41.0M, down 98.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PFE reported annual earnings of $2.1B, with -93.2% growth. The next PFE earnings date is Oct 29, 2024.
On PFE's earnings call on Invalid Date, Pfizer (NYSE: PFE) reported Q2 2024 earnings per share (EPS) of $0.01, up 97.56% year over year. Total PFE earnings for the quarter were $41.00 million. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.41.
The next PFE earnings date is Invalid Date. Add PFE to your watchlist to be reminded of Pfizer's next earnings date.
Is Pfizer profitable or losing money?
As of the last Pfizer earnings report, Pfizer is currently losing money. Pfizer's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$2.60 billion, a 112.08% decrease year over year.
What was PFE's earnings growth in the past year?
As of Pfizer's earnings date in Invalid Date, Pfizer's earnings has grown year over year. PFE earnings in the past year totalled -$2.60 billion.
What are Pfizer's earnings expectations?
The current EPS estimate for Pfizer's earnings report in Invalid Date is $0.59.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.